The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.
By T. Scott Stroup, J. McEvoy, M. Swartz, M. Byerly, I. Glick, J. Cañive, M. McGee, G. Simpson, Michael C. Stevens, J. Lieberman. 2003
642 citations recorded by the source corpus.
Subfields: Pharmacology, Psychiatry and Mental health
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
- Daniel J. Lizotte
- Eric B. Laber
- Michael H. Bowling
- Susan A. Murphy
- Michael R. Kosorok
- Ying‐Qi Zhao
- Susan M. Shortreed
- Abiral Baniya
In Psychiatry and Mental health
- Eric B. Laber
- Susan M. Shortreed
- Erica E. Moodie
- Daniel J. Lizotte
- Michael R. Kosorok
- Susan A. Murphy
- Ying‐Qi Zhao
- Michael H. Bowling
Citations in the corpus
- Informing sequential clinical decision-making through reinforcement learning: an empirical study (2010, methodology): “As this study is described in detail elsewhere (Stroup et al. 2003; Swartz et al. 2003), we give a simplified overview of the CATIE study here.”
- Set-valued dynamic treatment regimes for competing outcomes (2012, methodology): “The full study design is quite complex (Stroup et al., 2003); we will make several simplifications in order to more clearly illustrate the potential of our method.”
- Constructing evidence-based treatment strategies using methods from computer science. (2007, methodology): “We consider the use of reinforcement learning to analyze data from studies in which patients are randomized multiple, sequential, times (see Stone et al., 1995;Tummarello et al., 1997;Schneider et al., 2001,Fava et al., 2003;Stroup et al., 2003 for examples).”
- Estimation of Optimal Dynamic Treatment Regimes (2014, methodology): “Another complication is that the timing and number of clinic visits may be dependent on patient outcomes [29]; thus, a natural approach is to use multiple imputation and sequentially impute missing data as needed.”
- Multi-Objective Markov Decision Processes for Data-Driven Decision Support (2016, methodology): “The full study design is quite complex (Stroup and al, 2003; Swartz et al., 2003); we use a simplified subset of the CATIE data in order to more clearly illustrate the proposed methodology.”
- Linear Fitted-Q Iteration with Multiple Reward Functions (2012, methodology): “The full study design is quite complex (Stroup et al., 2003; Swartz et al., 2003); we have therefore chosen a simplified subset of the CATIE data in order to more clearly illustrate the potential of the methods presented in this paper.”
- Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules (2017, methodology): “The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial was designed to compare new antipsychotic drugs to conventional ones in a randomized, controlled, double blinded, multi-phase trial (Davis et al., 2003, 2011; Stroup et al., 2003; Lieberman et al., 2005).”
- Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study (2012, methodology): “One of the primary scientific questions of interest of the CATIE study was to compare the long-term effectiveness of newer atypical antipsychotics to perphenazine, which is a mid-potency first-generation antipsychotic (Stroup et al., 2003).”
- Q-learning Residual Analysis: Application to The Effectiveness of Sequences of Antipsychotic Medications for Patients with Schizophrenia (2016, methodology): “Here, we give only a brief and simplified description of the CATIE study, because the trial has already been described in detail elsewhere [19].”
- Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. (2007, neutral): “Never married 489 (60) 287 (57) 177 (60)”
- A national study of violent behavior in persons with schizophrenia. (2006, methodology): “Baseline assessments were conducted during a 1-time structured interview by trained clinical interviewers blind to random assignment for the subsequent follow-up study.(4,19)”
- Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (2005, neutral): “Female 92 (27) 82 (24) 88 (26) 62 (24) 56 (30) 380 (26)”
- Tractable Objectives for Robust Policy Optimization (2012, neutral): “, CATIE (H = 2) [16, 17] and STAR*D (H = 3) [14].”
- Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (2006, background): “org have been described in detail (10, 11).”